Cell News and Research

RSS

NKT, DSM sign contract to develop therapeutics based on natural killer T cells

DSM Biologics, a business unit of DSM Pharmaceutical Products, today announced the signing of a contract with NKT Therapeutics, Inc. based in Waltham, Mass, USA, the biotechnology company that focuses on developing therapeutics based on unique immune cells called natural killer T cells.

8 Feb 2011

Genentech's OCEANS Phase III study of Avastin in platinum-sensitive ovarian cancer meets primary endpoint

Genentech, a member of the Roche Group, announced today that OCEANS, a Phase III study evaluating Avastin® (bevacizumab) in combination with chemotherapy (carboplatin and gemcitabine) followed by continued use of Avastin alone until disease progression in women with previously treated (recurrent), platinum-sensitive ovarian cancer, met its primary endpoint.

8 Feb 2011

TREK1 activity offers a key target for fluoxetine and other antidepressant drugs

Using a unique and relatively simple cell-based fluorescent assay they developed, scientists with the U.S. Department of Energy's Lawrence Berkeley National Laboratory and the University of California, Berkeley have identified a means by which fluoxetine, the active ingredient in Prozac, suppresses the activity of the TREK1 potassium channel.

8 Feb 2011

Cleveland Clinic, JumpStart Ventures invest $500,000 in SironRX Therapeutics

JumpStart Ventures, the non-profit that invests in and partners with innovative, early-stage companies in Northeast Ohio, and Cleveland Clinic, announced a combined investment commitment of $500,000 in SironRX Therapeutics, Inc. The Cleveland-based company is developing a topical therapy to enhance healing of and decrease scar formation in wounds.

8 Feb 2011

Researchers develop new method for drug discovery using math to combat HIV, other diseases

Using mathematical concepts, Princeton researchers have developed a method of discovering new drugs for a range of diseases by calculating which physical properties of biological molecules may predict their effectiveness as medicines.

8 Feb 2011

Researchers identify enzyme that protects against inflammation, joint destruction

A team of researchers at the University of Gothenburg, Sweden, has identified an enzyme that protects against inflammation and joint destruction. Made when the researchers blocked production of the enzyme GGTase-I in transgenic mice, this unexpected discovery could lead to the identification of new mechanisms that control the development of inflammatory disorders, as well as new medicines.

8 Feb 2011

Tufts announces public launch of Institute for Biomedical Partnerships, HUB website

Tufts University today announced the public launch of the Tufts Institute for Biomedical Partnerships website/HUB: www.tuftspharmapartners.org.

8 Feb 2011

Researchers identify CHK1 protein may serve as treatment target for neuroblastoma

After analyzing hundreds of proteins produced by the DNA of tumor cells, researchers have identified one protein that may be central to a new treatment for the often-fatal childhood cancer neuroblastoma. Oncologists hope to translate the finding into pediatric clinical trials of a drug that blocks the protein's activity.

7 Feb 2011

USPTO issues key patent to ISTO's NuQu product for degenerative disc disease treatment

ISTO Technologies, Inc. announced today that the United States Patent and Trademark Office has granted the company a key patent covering the primary technology for ISTO's NuQu product.

7 Feb 2011

BD to acquire Accuri Cytometers

BD, a leading global medical technology company, announced today that it signed a definitive agreement to acquire Accuri Cytometers, Inc., an Ann Arbor, Michigan-based company that develops and manufactures personal flow cytometers for researchers.

From BD (Becton, Dickinson and Company) 7 Feb 2011

Mothballs may cause brain damage in babies: Experts

Pediatricians have called for a ban on the sale of mothballs containing the chemical naphthalene citing evidence that these can lead to severe blood problems and even brain damage for significant numbers of Australian babies.

7 Feb 2011

Harbor BioSciences closes U.S.-based Apoptone Phase I/IIa clinical trial for castration resistant prostate cancer

Harbor BioSciences, Inc., a biopharmaceutical company developing novel therapeutics for the treatment of cancer, metabolic and inflammatory diseases, today announced it is closing the clinical sites of its U.S.-based Phase I/IIa clinical trial with Apoptone® (HE3235) for castration resistant prostate cancer (CRPC) – also referred to as hormone resistant prostate cancer.

7 Feb 2011

Integra LifeSciences launches Integra Allograft Cancellous Sponge

Integra LifeSciences Holdings Corp announced today the launch of Integra Allograft Cancellous Sponge, a compressible bone graft composed of 100% cancellous bone. The sponge-like handling characteristics of Integra Allograft Cancellous Sponge allow it to absorb fluids like saline, blood or bone marrow aspirate.

7 Feb 2011

Human Vaccines journal publishes paper on Inovio's new DNA vaccine delivery technology

Inovio Pharmaceuticals, Inc., a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today that its new generation DNA vaccine delivery technology, which provides the powerful enabling capabilities of electroporation without contacting the skin, is highlighted in a paper published in the scientific journal Human Vaccines.

7 Feb 2011

Curaxis President comments on new Alzheimer's Association report

Patrick S. Smith, President and Chief Executive Officer of Curaxis Pharmaceutical Corp., commented today on a new report by the Alzheimer's Association, titled "Generation Alzheimer's – the defining disease of the baby boomers", which demonstrates the devastating impact and size of Alzheimer's disease.

7 Feb 2011

Baden-W-rttemberg's study and research to be presented at AAAS Annual Meeting 2011

Baden-W-rttemberg, the German Southwest, is the most innovative region in Europe, particularly dedicated to science and education. A share of 4.4 % of the State's GDP is invested in research and development - more than in most countries all around the world. Baden-W-rttemberg offers the highest density of research institutions and universities in Germany.

7 Feb 2011

Genomic study identifies link between Native American ancestry, relapse in young leukemia patients

The first genome-wide study to demonstrate an inherited genetic basis for racial and ethnic disparities in cancer survival linked Native American ancestry with an increased risk of relapse in young leukemia patients. The work was done by investigators at St. Jude Children's Research Hospital and the Children's Oncology Group.

6 Feb 2011

Wood smoke may create adverse health effects in humans

With millions of people warding off winter's chill with blazing fireplaces and wood-burning stoves, scientists are raising red flags about the potential health effects of the smoke released from burning wood. Their study, published in the American Chemical Society's journal, Chemical Research in Toxicology, found that the invisible particles inhaled into the lungs from wood smoke may have several adverse health effects.

6 Feb 2011

Diabetes Management – a new journal addressing the management issues of a complex disease

Future Medicine Ltd has today announced the launch of Diabetes Management – a new bimonthly title presenting findings, analyses and commentaries on the battle with Type 1 and Type 2 diabetes. Diabetes Management is published by Future Medicine Ltd (UK, London) renowned for its collection of journals providing healthcare practitioners and research professionals with a unique source of objective, cutting-edge information on exciting trends emerging in light of advances in medicine, healthcare and clinical practice.

6 Feb 2011

Blood vessels for heart bypass could be available ‘off-the-shelf’ soon: Study

Scientists from USA have developed a method to produce a ready made supply of blood vessels for use in heart bypass surgery. A study on baboons and dogs reported in journal Science Translational Medicine suggests vessels could be stored for up to a year and used by any patient. These vessels have been grown earlier from a patient’s own cells, but this takes several months.

6 Feb 2011

Cell News and Research

NKT, DSM sign contract to develop therapeutics based on natural killer T cells

Genentech's OCEANS Phase III study of Avastin in platinum-sensitive ovarian cancer meets primary endpoint

TREK1 activity offers a key target for fluoxetine and other antidepressant drugs

Cleveland Clinic, JumpStart Ventures invest $500,000 in SironRX Therapeutics

Researchers develop new method for drug discovery using math to combat HIV, other diseases

Researchers identify enzyme that protects against inflammation, joint destruction

Tufts announces public launch of Institute for Biomedical Partnerships, HUB website

Researchers identify CHK1 protein may serve as treatment target for neuroblastoma

USPTO issues key patent to ISTO's NuQu product for degenerative disc disease treatment

BD to acquire Accuri Cytometers

Mothballs may cause brain damage in babies: Experts

Harbor BioSciences closes U.S.-based Apoptone Phase I/IIa clinical trial for castration resistant prostate cancer

Integra LifeSciences launches Integra Allograft Cancellous Sponge

Human Vaccines journal publishes paper on Inovio's new DNA vaccine delivery technology

Curaxis President comments on new Alzheimer's Association report

Baden-W-rttemberg's study and research to be presented at AAAS Annual Meeting 2011

Genomic study identifies link between Native American ancestry, relapse in young leukemia patients

Wood smoke may create adverse health effects in humans

Diabetes Management – a new journal addressing the management issues of a complex disease

Blood vessels for heart bypass could be available ‘off-the-shelf’ soon: Study

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest Life Science News